Natixis Advisors LLC Decreases Stake in Kenvue Inc. $KVUE

Natixis Advisors LLC lowered its position in shares of Kenvue Inc. (NYSE:KVUE) by 69.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 296,048 shares of the company’s stock after selling 659,258 shares during the quarter. Natixis Advisors LLC’s holdings in Kenvue were worth $5,107,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of KVUE. Norges Bank purchased a new stake in shares of Kenvue during the 4th quarter worth about $756,862,000. Van ECK Associates Corp grew its holdings in shares of Kenvue by 101.3% during the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock worth $298,008,000 after purchasing an additional 9,240,434 shares during the period. American Century Companies Inc. grew its holdings in shares of Kenvue by 22.4% during the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock worth $601,267,000 after purchasing an additional 6,781,640 shares during the period. Bessemer Group Inc. grew its holdings in shares of Kenvue by 156.2% during the 4th quarter. Bessemer Group Inc. now owns 8,491,343 shares of the company’s stock worth $146,475,000 after purchasing an additional 5,177,404 shares during the period. Finally, Mondrian Investment Partners LTD purchased a new stake in shares of Kenvue during the 3rd quarter worth about $79,269,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Activity

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.59% of the stock is currently owned by insiders.

Analysts Set New Price Targets

KVUE has been the subject of a number of research reports. UBS Group decreased their target price on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. Citigroup decreased their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Argus upgraded Kenvue to a “hold” rating in a report on Friday, March 6th. Canaccord Genuity Group upped their price target on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Finally, Barclays decreased their price target on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $19.33.

Kenvue Stock Performance

Shares of KVUE opened at $17.56 on Tuesday. The business’s 50 day moving average is $17.37 and its two-hundred day moving average is $17.49. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $22.87. The firm has a market cap of $33.71 billion, a price-to-earnings ratio of 20.65, a PEG ratio of 1.34 and a beta of 0.54. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same period in the prior year, the company posted $0.24 EPS. Kenvue’s quarterly revenue was up 4.5% on a year-over-year basis. Analysts forecast that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.